Cross-sector
From selective consolidation to strategic reinvention: 3 drivers shaping MedTech M&A in 2026
The momentum from 2025 is carrying decisively into 2026. After a year defined by selective, high-value consolidation, the MedTech M&A will likely be shaped less by deal volume and more by ...









